Grauer And Weil (India) Ltd
NSE:GRAUWEIL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Grauer And Weil (India) Ltd
NSE:GRAUWEIL
|
IN |
|
M
|
MFO SA
WSE:MFO
|
PL |
|
BOC Hong Kong Holdings Ltd
HKEX:2388
|
HK |
|
E
|
eMagin Corp
F:EMGA
|
US |
|
Bright Health Group Inc
NYSE:NEUE
|
US |
|
Turkiye Sise ve Cam Fabrikalari AS
IST:SISE.E
|
TR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GRAUWEIL's stock price target?
Not Available
GRAUWEIL doesn't have any price targets made by Wall Street professionals.
What is Grauer And Weil (India) Ltd's Revenue forecast?
Projected CAGR
-13%
For the last 8 years the
compound annual growth rate for
Grauer And Weil (India) Ltd's revenue is
11%.
The projected
CAGR
for the next 3 years is
-13%.
What is Grauer And Weil (India) Ltd's Operating Income forecast?
Projected CAGR
-6%
For the last 8 years the
compound annual growth rate for
Grauer And Weil (India) Ltd's operating income is
11%.
The projected
CAGR
for the next 3 years is
-6%.
What is Grauer And Weil (India) Ltd's Net Income forecast?
Projected CAGR
-12%
For the last 8 years the
compound annual growth rate for
Grauer And Weil (India) Ltd's net income is
16%.
The projected
CAGR
for the next 3 years is
-12%.